Skip to main content
. 2022 Mar;10(6):367. doi: 10.21037/atm-22-1126

Figure 3.

Figure 3

Cumulative survival analyses of time between re-hospitalization in subgroups. (A) Cumulative survival analysis in the control group, pre-sarcopenia group and sarcopenia group. (B) Cumulative survival analysis of time in sarcopenic obesity group and non-sarcopenic obesity group. IBD, inflammatory bowel disease; BMI, body mass index.